...
首页> 外文期刊>Neurorehabilitation and neural repair >Long-Term Follow-up to a Randomized Controlled Trial Comparing Peroneal Nerve Functional Electrical Stimulation to an Ankle Foot Orthosis for Patients With Chronic Stroke
【24h】

Long-Term Follow-up to a Randomized Controlled Trial Comparing Peroneal Nerve Functional Electrical Stimulation to an Ankle Foot Orthosis for Patients With Chronic Stroke

机译:对慢性卒中患者的腓肠神经功能性电刺激与踝足矫形器进行比较的随机对照试验的长期随访

获取原文
获取原文并翻译 | 示例

摘要

Background. Evidence supports peroneal nerve functional electrical stimulation (FES) as an effective alternative to ankle foot orthoses (AFO) for treatment of foot drop poststroke, but few long-term, randomized controlled comparisons exist. Objective. Compare changes in gait quality and function between FES and AFOs in individuals with foot drop poststroke over a 12-month period. Methods. Follow-up analysis of an unblinded randomized controlled trial (ClinicalTrials.gov #NCT01087957) conducted at 30 rehabilitation centers comparing FES to AFOs over 6 months. Subjects continued to wear their randomized device for another 6 months to final 12-month assessments. Subjects used study devices for all home and community ambulation. Multiply imputed intention-to-treat analyses were utilized; primary endpoints were tested for noninferiority and secondary endpoints for superiority. Primary endpoints: 10 Meter Walk Test (10MWT) and device-related serious adverse event rate. Secondary endpoints: 6-Minute Walk Test (6MWT), GaitRite Functional Ambulation Profile, and Modified Emory Functional Ambulation Profile (mEFAP). Results. A total of 495 subjects were randomized, and 384 completed the 12-month follow-up. FES proved noninferior to AFOs for all primary endpoints. Both FES and AFO groups showed statistically and clinically significant improvement for 10MWT compared with initial measurement. No statistically significant between-group differences were found for primary or secondary endpoints. The FES group demonstrated statistically significant improvements for 6MWT and mEFAP Stair-time subscore. Conclusions. At 12 months, both FES and AFOs continue to demonstrate equivalent gains in gait speed. Results suggest that long-term FES use may lead to additional improvements in walking endurance and functional ambulation; further research is needed to confirm these findings.
机译:背景。证据支持腓神经神经电刺激(FES)作为踝足矫形器(AFO)治疗中风后足下垂的有效替代方法,但很少有长期,随机对照的比较。目的。比较12个月内中风后有脚下降的个体的FES和AFO之间步态质量和功能的变化。方法。在30个康复中心进行的一项无盲随机对照试验(ClinicalTrials.gov#NCT01087957)的随访分析,比较了6个月内FES和AFO。受试者继续佩戴其随机装置另外6个月,以进行最终的12个月评估。受试者使用学习设备进行所有家庭和社区移动。使用了多重估算的意向治疗分析;对主要终点进行了非劣性测试,对次要终点进行了优越性测试。主要终点:10米步行测试(10MWT)和与设备相关的严重不良事件发生率。次要终点:6分钟步行测试(6MWT),GaitRite功能性运动曲线和改良的Emory功能性运动曲线(mEFAP)。结果。总共495名受试者被随机分组​​,其中384名受试者完成了12个月的随访。事实证明,FES在所有主要终点均不逊于AFO。与初始测量相比,FES和AFO组均显示10MWT的统计学和临床​​显着改善。没有发现主要终点或次要终点之间有统计学意义的组间差异。 FES组证明了6MWT和mEFAP Stair-time评分的统计显着改善。结论在12个月时,FES和AFO都继续在步态速度上表现出同等的增长。结果表明,长期使用FES可能会进一步改善步行耐力和运动能力;需要进一步的研究来确认这些发现。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号